Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022.

Carla AbdelnourMaria Camila GonzalezLucy L GibsonKathleen L PostonClive G BallardJeffrey L CummingsDag Aarsland

Published in: Neurology and therapy (2023)

Current challenges in DLB clinical trials include the need for disease-specific outcome measures and biomarkers, and improving representation of global and diverse populations.

Keyphrases

clinical trial
systematic review
meta analyses
phase ii
mild cognitive impairment
cognitive impairment
study protocol
open label
parkinson disease
randomized controlled trial
phase iii
double blind
drug induced
adverse drug